 |
|
||||||||||||||||||
    
 |
|||||||||||||||||||
| About | Ahead of print | Current Issue | Archive | Search | Instructions | Advertise | Contact |
|
|||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||
|
 Reader
Comments
Year : 2021 | Volume: 58 | Issue Number: 1 MCQSMCQs on “Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment” Darling H S, Jaiswal Pradeep, Lohia Nishant, Tiwari Nishant R
|
|||||||||||||
|
